Advertisement
Advertisement

ANIX

ANIX logo

Anixa Biosciences Inc

2.56
USD
-0.18
-6.57%
Dec 18, 15:59 UTC -5
Closed
...

Anixa Biosciences Inc Profile

About

Anixa Biosciences, Inc. operates as a bio-technology company. It develops diagnostics and therapeutics to detect cancer. Anixa Biosciences Inc., formerly known as ITUS Corporation, is based in San Jose, United States.

Info & Links

CEO

Amit Kumar

Headquarters

3150 ALMADEN EXPRESSWAY, SUITE 250
SAN JOSE, CA 95118, UNITED STATES

Auditor

HASKELL & WHITE LLP

Share holders

312

Employees

5

Anixa Biosciences Inc Statistics

Valuation Measures

Market Capitalization2

82.38M

Enterprise Value

81.16M

Enterprise Value/EBITDA(ttm)

-5.93

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

4.41

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-54.79%

Return on Invested Capital(ttm)

-55.69%

Return on Assets(ttm)

-50.37%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-13.68M

Net Income Available to Common(ttm)

-12.36M

Diluted EPS(ttm)

-0.39

Share Statistics

Beta (5Y Monthly)

0.82

52-Week Change

-30.62%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

32.18M

Dividend Yield

0.00%

Float4

24.91M

% Held by Insiders

22.60%

% Held by Institutions

29.13%

Balance Sheet

Total Cash(mrq)

20.75M

Total Cash Per Share(mrq)

0.64

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

11.31%

Quick Ratio(mrq)

11.31%

Book Value Per Share(mrq)

0.64

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.20

Free Cash Flow(ytd)

-6.41M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement